Trial Profile
A retrospective study of sunitinib with transarterial chemoembolization versus transarterial chemoembolization alone in the treatment of advanced-stage hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2015
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Sep 2015 New trial record